Acasti Pharma Inc.
ACST
Rank in Stocks
#29766
Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research,... Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research, development, and market introduction of pharmaceutical solutions for cardiovascular conditions. The firm is currently exploring strategic collaborations to further the clinical advancement of its compound, CaPre. Established in 2002, Acasti Pharma Inc. maintains its principal operations from its headquarters in Laval, Canada.
Share Price
$0.4256834
Last synced: 2023-03-27
Market Cap
$18.99M
Change (1 day)
3.08%
Change (1 year)
-87.02%
Country
CA
Trade Acasti Pharma Inc. (ACST)
Category
Healthcare
EPS for Acasti Pharma Inc. (ACST)
EPS as of June 2026 TTM: $-1.17
According to Acasti Pharma Inc. latest financial reports and stock price the company's current EPS (TTM) is $-1.17. At the end of 2024 the company had a EPS of $-1.35 a decrease compared to its 2023 EPS that were of $-5.71.
EPS history for Acasti Pharma Inc. from 2010 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.17 | 48.10% |
| 2025 | $-0.79 | -41.48% |
| 2024 | $-1.35 | -76.36% |
| 2023 | $-5.71 | 256.88% |
| 2022 | $-1.60 | -79.90% |
| 2021 | $-7.96 | -5.01% |
| 2020 | $-8.38 | 73.17% |
| 2019 | $-4.84 | -19.49% |
| 2018 | $-6.01 | -61.25% |
| 2016 | $-15.51 | 224.41% |
| 2015 | $-4.78 | -91.08% |
| 2014 | $-53.58 | 24.03% |
| 2013 | $-43.20 | -8.51% |
| 2012 | $-47.22 | 102.66% |
| 2011 | $-23.30 | -26.64% |
| 2010 | $-31.76 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $17.32 | -1,580.34% |
US
|
|
| $-7.98 | 582.05% |
US
|
|
| $-5.29 | 352.14% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -2,470.94% |
NL
|
